峰瑞资本
@author-1781068851320
7 Interdisciplinary Companies Close New Funding Rounds | FreeS Family Funding News Vol.22
Looking forward to working alongside more outstanding founders.
Venture Capital Lens on the Two Sessions: Six Core Topics and Policy Roundup | FreeS Research --- Every March, China's "Two Sessions" — the annual meetings of the National People's Congress (NPC) and the Chinese People's Political Consultative Conference (CPPCC) — draw widespread attention. For investors and entrepreneurs, the government work report and policy signals released during this period serve as a critical compass for the year ahead. In this article, the FreeS Research team examines the 2024 Two Sessions through a venture capital lens, identifying six core topics most relevant to the tech and startup ecosystem: **AI and digital economy, hard tech and advanced manufacturing, new energy and carbon neutrality, biotech and healthcare, consumption and domestic circulation,** and **capital markets and fundraising environment.** We also map out the specific policy measures and investment implications for each. --- ## 1. AI and the Digital Economy: From "Development" to "Application" AI was elevated to a new level of urgency at this year's Two Sessions. The government work report explicitly called for **"deepening R&D and application of AI"** and **"launching the 'AI+' initiative"** — a notable shift from previous years' emphasis on "development" and
Hoping this can offer a fresh perspective and some food for thought.
Deep Dive: China's "DeepSeek Moment" in Biotech | FreeS Fund Report
A Watershed Year for China's Innovative Drug Industry
DeepSeek Fired the First Shot, but AI Democratization Is What Really Matters | A Conversation with Yu Ji of Xingyun Integrated Circuit
Where is the moat for large language model companies?
The Perfect Storm Behind *Nezha 2*'s Blockbuster Success | FreeS Research FreeS Fund
*Nezha 2*: What Its Blockbuster Success Reveals About Culture, Technology, and Investment
3/2 Suzhou Offline Event Registration | The 4th Biomedical Innovation and Translation Summit
Exploring the Path of Innovation and Translation in Biomedicine, Together
A Deep Dive into 7 Core Questions About DeepSeek | FreeS Fund Report
In an era of rapid AI advancement, the DeepSeek story is only just beginning.
LimX Dynamics Founder: How Do Intelligent Robots Go From "Usable" to "Productive" to "Profitable"?
The Commercial Challenges and Opportunities of Embodied Intelligence
Here are 13 industry research reports and a podcast episode to get you off to a strong start.
Let's explore the cutting edge and discover new knowledge.
FreeS Fund's 2024 Year in Review: Going Further Together, Doing What's Right Rather Than What's Easy
Thank you to every friend who has journeyed alongside FreeS Fund.
As the year draws to a close, five companies secure new funding to carry momentum into 2025 | FreeS Family Funding News Vol. 21
Looking forward to working alongside more outstanding founders.
2025: Three Directions Where AI Is Reshaping Drug Discovery
How Can AI Help Drug Development Cross the "Valley of Death"?